Cysteamine exerts in vitro antiviral activity against the SARS-CoV-2 Delta and Omicron variants.

Alonzi, Tonino; Aiello, Alessandra; Repele, Federica; Falasca, Laura; Francalancia, Massimo; Garbuglia, Anna Rosa; Delogu, Giovanni; Nicastri, Emanuele; Piacentini, Mauro; Goletti, Delia

Alonzi, Tonino; Aiello, Alessandra; Repele, Federica; Falasca, Laura; Francalancia, Massimo; Garbuglia, Anna Rosa; Delogu, Giovanni; Nicastri, Emanuele; Piacentini, Mauro; Goletti, Delia.

Afiliação

Alonzi T; National Institute for Infectious Diseases "L. Spallanzani"-IRCCS, Rome, Italy.
Aiello A; National Institute for Infectious Diseases "L. Spallanzani"-IRCCS, Rome, Italy.
Repele F; National Institute for Infectious Diseases "L. Spallanzani"-IRCCS, Rome, Italy.
Falasca L; National Institute for Infectious Diseases "L. Spallanzani"-IRCCS, Rome, Italy.
Francalancia M; National Institute for Infectious Diseases "L. Spallanzani"-IRCCS, Rome, Italy.
Garbuglia AR; National Institute for Infectious Diseases "L. Spallanzani"-IRCCS, Rome, Italy.
Delogu G; Institute of Microbiology, Università Cattolica del Sacro Cuore - Fondazione Policlinico Gemelli, Rome, Italy.
Nicastri E; Mater Olbia Hospital, Olbia, Italy.
Piacentini M; National Institute for Infectious Diseases "L. Spallanzani"-IRCCS, Rome, Italy.
Goletti D; National Institute for Infectious Diseases "L. Spallanzani"-IRCCS, Rome, Italy. mauro.piacentini@uniroma2.it.

Cell Death Discov ; 8(1): 288, 2022 Jun 15.

Article em En | MEDLINE | ID: mdl-35705564

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Cell Death Discov Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google